Crossmark

Baseline and post-treatment biomarkers of resistance to anti-PD-1 therapy in acral and mucosal melanoma: an observational study

Crossref DOI link: https://doi.org/10.1136/jitc-2022-004879

Published Online: 2022-07-06

Published Print: 2022-07

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Shui, Irene M. https://orcid.org/0000-0001-5737-9830
Liu, Xiao Qiao

Zhao, Qing

Kim, Seung Tae

Sun, Yuan

Yearley, Jennifer H.

Choudhury, Tasmiah

Webber, Andrea L.

Krepler, Clemens

Cristescu, Razvan

Lee, Jeeyun
Funding

Funding for this research was provided by:

Merck Sharp & Dohme LLC
License Information

License valid from 2022-07-06